July 4, 2016
English Court to consider Premaitha’s defence on Illumia filed case after hearing scheduled for July 2017
English Court to consider Premaitha’s defence after hearing scheduled for July 2017
Pharmaceuticals, Biotechnology and Life Sciences
Tag: featured
July 1, 2016
AstraZeneca, LEO Pharma agree on Trolakinumab global rights deal
AstraZeneca has entered into an agreement with LEO Pharma A/S (LEO Pharma), a specialist in dermatology care, for the global licence to tralokinumab in skin diseases. As explained by AstraZeneca, Tralokinumab is a potential new medicine (an anti-IL-13 monoclonal antibody) that has completed a Phase IIb trial for the treatment of patients with atopic dermatitis, an inflammatory skin disease resulting in itchy, red, swollen and cracked skin.
April 5, 2016
Diplomat’s Taltz approved for treatment of plaque psoriasis
TALTZ was recently approved by the U.S. Food and Drug Administration to treat adults with moderate-to-severe plaque psoriasis.
April 5, 2016
New U.S. inversion rules threaten Pfizer-Allergan deal
The U.S. Treasury Department took new steps on Monday to curb tax-avoiding corporate “inversions,” with the pending $160 billion merger of Pfizer Inc and Allergan Plc seen as a potential casualty.
March 29, 2016
Sanofi poaches AstraZeneca scientist as new research head
drugmaker Sanofi has poached one of AstraZeneca’s top scientists to be its new research head in another high-profile departure for the British drugmaker.
March 23, 2016
AstraZeneca’s Brilianta tablets efficient in prevention of major vascular events
AstraZeneca on Wednesday announced the results of the SOCRATES trial, assessing the efficacy of Brilinta/Brilique (ticagrelor) 90 mg tablets twice daily, when compared to aspirin 100mg once daily in patients with acute ischaemic stroke or transient ischaemic attack (TIA)
March 22, 2016
Drugmaker Valeant CEO leaving as investor Ackman joins the board
Drugmaker Valeant Pharmaceuticals International Inc said on Monday its chief executive officer is leaving and billionaire investor William Ackman would join the board as it tries to clean up accounting problems and save its business.
March 16, 2016
FDA warns public about eye drop bottles with loose safety seals
FDA warns public about eye drop bottles with loose safety seals
March 15, 2016
Lilly includes a single primary endpoint of cognition (ADAS-Cog14) to EXPEDITION3 trial
Lilly includes a single primary endpoint of cognition (ADAS-Cog14) to EXPEDITION3 trial